EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Myxovirus resistance protein A (MxA) expression in myositides: Sarcoplasmic expression is common in both dermatomyositis and lupus myositis

Changhong Xing iD, Jaya Trivedi, Nicole Bitencourt iD, Dennis K Burns, Joan S Reisch, Chunyu Cai iD

Muscle & Nerve · 2024-05 · 69 (5) · 548-555

DOI: 10.1002/mus.28066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 19.02.2024. Verfasst von Changhong Xing und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Dermatomyositis, Muscular Diseases, Myositis, Orthomyxoviridae. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Pathology, UTSW Medical Center, Department of Pathology, Northwestern University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Myxovirus resistance protein A (MxA) is a type I interferon (IFN1) pathway activation marker and MxA sarcoplasmic expression is currently recognized as a highly specific marker for dermatomyositis (DM). However, we have frequently observed endothelial tubuloreticular inclusions (TRI), another surrogate IFN1 activation marker, in a variety of overlap myositides. The aim of this study was to examine MxA expression in those myositides.

Methods

We retrospectively performed MxA immunostaining on a wide range of myositides.

Results

MxA sarcoplasmic expression was present in DM (94.4%, 17/18), active lupus myositis (LM, 80%,16/20), inactive LM (36%, 4/11), antisynthetase syndrome (ASyS, 20%, 2/10), systemic sclerosis (13%, 2/15), Sjogren's syndrome (7.7%, 1/13), and human immunodeficiency virus (HIV) myositis (5.6%, 1/18) and was absent in immune‐mediated necrotizing myopathy (IMNM, 0/16) and hydroxychloroquine myopathy (0/5). The sensitivity and specificity of MxA sarcoplasmic expression for LM and DM combined compared with all other myositides were 84.6% (95% CI: 69.5–94.1) and 92.1 (95% CI: 83.6–97.0), respectively, and superior to TRIs. MxA capillary expression was nonspecific. Histologically, 35% of LM cases demonstrated a unique panfascicular necrotizing myopathy pattern. The remainder of the LM cases had significant morphological overlap with DM/ASyS (20%), IMNM (20%), or polymyositis (15%).

Discussion

MxA sarcoplasmic expression is highly prevalent in LM and DM and is a useful marker in differentiating DM and LM from other myositides. LM can manifest in various pathology patterns that need to be differentiated from DM, IMNM, ASyS, and polymyositis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatomyositisMuscular DiseasesMyositisOrthomyxoviridaePolymyositisHumansBiomarkersRetrospective Studies

Stichwörter der Autor:innen

dermatomyositisinflammatory myopathyinterferonmuscle biopsypathologysystemic lupus erythematosus

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Changhong Xing, Nicole Bitencourt, Chunyu Cai

Förderung

  • Department of Pathology, UTSW Medical Center
  • Department of Pathology, Northwestern University

Zitieren

APA

Xing, C., Trivedi, J., Bitencourt, N., Burns, D. K., Reisch, J. S., & Cai, C. (2024). Myxovirus resistance protein A (MxA) expression in myositides: Sarcoplasmic expression is common in both dermatomyositis and lupus myositis. Muscle & Nerve, 69(5), 548-555. https://doi.org/10.1002/mus.28066

Vancouver

Xing C, Trivedi J, Bitencourt N, Burns DK, Reisch JS, Cai C. Myxovirus resistance protein A (MxA) expression in myositides: Sarcoplasmic expression is common in both dermatomyositis and lupus myositis. Muscle & Nerve. 2024;69(5):548-555. doi:10.1002/mus.28066

BibTeX
@article{Xing2024,
  author = {Xing, Changhong and Trivedi, Jaya and Bitencourt, Nicole and Burns, Dennis K and Reisch, Joan S and Cai, Chunyu},
  title = {Myxovirus resistance protein A (MxA) expression in myositides: Sarcoplasmic expression is common in both dermatomyositis and lupus myositis},
  journal = {Muscle & Nerve},
  year = {2024},
  volume = {69},
  number = {5},
  pages = {548--555},
  doi = {10.1002/mus.28066}
}
Kostenlos starten →